Dynamic 18F-fluorocholine PET/CT for parathyroid imaging in patients with primary hyperparathyroidism.


Journal

Nuclear medicine communications
ISSN: 1473-5628
Titre abrégé: Nucl Med Commun
Pays: England
ID NLM: 8201017

Informations de publication

Date de publication:
Aug 2020
Historique:
pubmed: 27 5 2020
medline: 13 5 2021
entrez: 27 5 2020
Statut: ppublish

Résumé

In the past few years, F-fluorocholine PET/CT has been established as a promising imaging technique for preoperative localization of parathyroid adenomas, but the optimal time point to start PET/CT acquisition after tracer injection is yet unknown. The aim of the present study was to assess the optimal time frame to acquire the PET/CT images and to evaluate the ability of dynamic imaging to differentiate parathyroid adenomas from active lymph nodes, a common cause for false-positive scan results. Patients with primary hyperparathyroidism who had undergone a dynamic F-fluorocholine PET/CT positive for parathyroid disease and who subsequently underwent successful parathyroidectomy were retrospectively included in this study. On the 20 minutes dynamic images, standardized uptake value measurements were acquired per 1 minute frame for the parathyroid adenoma, the thyroid gland, blood pool activity, and, if present, lymph node activity. A total of 101 patients were included in this study. Time-activity curves showed a decrease of activity in parathyroid and thyroid glands, with faster wash-out from the thyroid gland and on average a stable, lower activity in lymph nodes. Blood pool activity was particularly present in the first 2 minutes. Differentiation of a parathyroid adenoma from active lymph nodes was best before 5 minutes, but no definitive cutoff value could be determined. Differentiation of a parathyroid adenoma from the thyroid gland was best after 10 minutes. Dynamic imaging starting at the early time point of 2 minutes after injection of F-fluorocholine is useful for characterization of hyperfunctioning parathyroid glands.

Identifiants

pubmed: 32453204
doi: 10.1097/MNM.0000000000001217
pii: 00006231-202008000-00010
doi:

Substances chimiques

fluoromethylcholine 0
Choline N91BDP6H0X

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

776-782

Références

Sackett WR, Barraclough B, Reeve TS, Delbridge LW. Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg. 2002; 137:1055–1059
Mapelli P, Busnardo E, Magnani P, Freschi M, Picchio M, Gianolli L, Messa C. Incidental finding of parathyroid adenoma with 11C-choline PET/CT. Clin Nucl Med. 2012; 37:593–595
Treglia G, Piccardo A, Imperiale A, Strobel K, Kaufmann PA, Prior JO, Giovanella L. Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2019; 46:751–765
Broos WAM, van der Zant FM, Knol RJJ, Wondergem M. Choline PET/CT in parathyroid imaging: a systematic review. Nucl Med Commun. 2019; 40:96–105
Rep S, Hocevar M, Vaupotic J, Zdesar U, Zaletel K, Lezaic L. 18F-choline PET/CT for parathyroid scintigraphy: significantly lower radiation exposure of patients in comparison to conventional nuclear medicine imaging approaches. J Radiol Prot. 2018; 38:343–356
Rep S, Lezaic L, Kocjan T, Pfeifer M, Sever MJ, Simoncic U, et al. Optimal scan time for evaluation of parathyroid adenoma with [(18)F]-fluorocholine PET/CT. Radiol Oncol. 2015; 49:327–333
Broos WAM, Wondergem M, van der Zant FM, Knol RJJ. Dual-time-point 18F-fluorocholine PET/CT in parathyroid imaging. J Nucl Med. 2019; 60:1605–1610
Oprea-Lager DE, Vincent AD, van Moorselaar RJ, Gerritsen WR, van den Eertwegh AJ, Eriksson J, et al. Dual-phase PET-CT to differentiate [18F]fluoromethylcholine uptake in reactive and malignant lymph nodes in patients with prostate cancer. PLoS One. 2012; 7:e48430
Prabhu M, Kumari G, Damle NA, Arora G, Kumar P, Kumar R, et al. Assessment of the role of early dynamic PET/CT with 18F-fluorocholine in detection of parathyroid lesions in patients with primary hyperparathyroidism. Nucl Med Commun. 2018; 39:1190–1196
Lodge MA, Chaudhry MA, Wahl RL. Noise considerations for PET quantification using maximum and peak standardized uptake value. J Nucl Med. 2012; 53:1041–1047
Vellani C, Hodolič M, Chytiris S, Trifirò G, Rubello D, Colletti PM. Early and delayed 18F-FCH PET/CT imaging in parathyroid adenomas. Clin Nucl Med. 2017; 42:143–144
Prabhu M, Kumari G, Damle NA, Arora G, Tripathi M, Bal C, et al. Comparability of early dynamic and conventional static imaging with 18F-fluorocholine PET/CT in a Patient with primary hyperparathyroidism. Clin Nucl Med. 2018; 43:e400–e401
Raghavan P, Durst CR, Ornan DA, Mukherjee S, Wintermark M, Patrie JT, et al. Dynamic CT for parathyroid disease: are multiple phases necessary? AJNR Am J Neuroradiol. 2014; 35:1959–1964
Piccardo A, Trimboli P, Rutigliani M, Puntoni M, Foppiani L, Bacigalupo L, et al. Additional value of integrated 18F-choline PET/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile. Eur J Nucl Med Mol Imaging. 2019; 46:766–775
Michaud L, Burgess A, Huchet V, Lefèvre M, Tassart M, Ohnona J, et al. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? J Clin Endocrinol Metab. 2014; 99:4531–4536
Michaud L, Balogova S, Burgess A, Ohnona J, Huchet V, Kerrou K, et al. A pilot comparison of 18F-fluorocholine PET/CT, ultrasonography and 123I/99mTc-sestaMIBI Dual-phase dual-isotope scintigraphy in the preoperative localization of hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism: influence of thyroid anomalies. Medicine (Baltimore). 2015; 94:e1701
Morland D, Richard C, Godard F, Deguelte S, Delemer B. Temporal uptake patterns of 18F-fluorocholine among hyperfunctioning parathyroid glands. Clin Nucl Med. 2018; 43:504–505
Noltes ME, Kruijff S, Noordzij W, Telenga ED, Vállez García D, Trofimiuk-Müldner M, et al. Optimization of parathyroid 11C-choline PET protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidism. EJNMMI Res. 2019; 9:73
Haroon A, Zanoni L, Celli M, Zakavi R, Beheshti M, Langsteger W, et al. Multicenter study evaluating extraprostatic uptake of 11C-choline, 18F-methylcholine, and 18F-ethylcholine in male patients: physiological distribution, statistical differences, imaging pearls, and normal variants. Nucl Med Commun. 2015; 36:1065–1075
Evangelista L, Zattoni F, Guttilla A, Saladini G, Zattoni F, Colletti PM, Rubello D. Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis. Clin Nucl Med. 2013; 38:305–314
Lappas D, Noussios G, Anagnostis P, Adamidou F, Chatzigeorgiou A, Skandalakis P. Location, number and morphology of parathyroid glands: results from a large anatomical series. Anat Sci Int. 2012; 87:160–164
Christakis I, Khan S, Sadler GP, Gleeson FV, Bradley KM, Mihai R. 18Fluorocholine PET/CT scanning with arterial phase-enhanced CT is useful for persistent/recurrent primary hyperparathyroidism: first UK case series results. Ann R Coll Surg Engl. 2019; 101:501–507
Amadou C, Bera G, Ezziane M, Chami L, Delbot T, Rouxel A, et al. 18F-fluorocholine PET/CT and parathyroid 4D computed tomography for primary hyperparathyroidism: the challenge of reoperative patients. World J Surg. 2019; 43:1232–1242

Auteurs

Wouter A M Broos (WAM)

Department of Nuclear Medicine, Northwest Clinics, Alkmaar.
CAPHRI School for Care and Public Health Research.

Maurits Wondergem (M)

Department of Nuclear Medicine, Northwest Clinics, Alkmaar.

Friso M van der Zant (FM)

Department of Nuclear Medicine, Northwest Clinics, Alkmaar.

Nicolaas C Schaper (NC)

CAPHRI School for Care and Public Health Research.
Department of Internal Medicine, Division of Endocrinology, Maastricht University Medical Centre, Maastricht, The Netherlands.

Remco J J Knol (RJJ)

Department of Nuclear Medicine, Northwest Clinics, Alkmaar.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH